Epidemiology of multidrug resistant Gram-negative bacteria: Are we close to the « post antibiotic era »?

Thierry Naas
Microbiologist, Hôpital de Bicêtre, EA7361, University Paris Sud, CNR associé Résistance aux carbapénèmes

Multidrug resistant bacteria are developing so fast that the burden of deaths due to these bacteria could be 10 million lives/year by 2050 - with an estimated cost of 1,000 trillion USD! In this short presentation, Dr. Naas highlights this crucial problem by explaining the mechanisms behind Gram-negative bacteria resistance as well as the epidemiology of extended spectrum ß-lactamase and carbapenem-resistance. He also presents possible solutions that can be used in this time-sensitive fight.

Neueste Kurzpräsentationen